David Toung
Stock Analyst at Argus Research
(3.36)
# 1,022
Out of 5,099 analysts
129
Total ratings
65%
Success rate
9.96%
Average return
Main Sectors:
Stocks Rated by David Toung
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TECH Bio-Techne | Maintains: Buy | $65 → $68 | $60.83 | +11.79% | 4 | Nov 20, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $580 → $610 | $573.81 | +6.31% | 8 | Oct 29, 2025 | |
| HOLX Hologic | Maintains: Buy | $80 → $90 | $74.83 | +20.27% | 2 | Sep 19, 2025 | |
| MDT Medtronic | Maintains: Buy | $105 → $115 | $100.77 | +14.12% | 7 | Aug 26, 2025 | |
| HUM Humana | Reiterates: Hold | $282 | $256.66 | +9.87% | 9 | Aug 14, 2025 | |
| ELV Elevance Health | Downgrades: Hold | n/a | $341.04 | - | 4 | Jul 21, 2025 | |
| GFS GlobalFoundries | Initiates: Buy | $52 | $40.42 | +28.65% | 1 | Jul 1, 2025 | |
| UNH UnitedHealth Group | Downgrades: Hold | n/a | $328.37 | - | 8 | Apr 21, 2025 | |
| IART Integra LifeSciences Holdings | Upgrades: Buy | n/a | $13.66 | - | 2 | Mar 31, 2025 | |
| ABBV AbbVie | Upgrades: Buy | n/a | $225.18 | - | 6 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $125 | $198.21 | -36.94% | 9 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $194.85 | - | 5 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $300 → $340 | $315.38 | +7.81% | 10 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $570 → $670 | $813.10 | -17.60% | 6 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $150 | $93.09 | +61.13% | 7 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $770 → $840 | $993.64 | -15.46% | 3 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $84.47 | +30.22% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $261.99 | - | 1 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $25.78 | - | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $353.80 | -12.38% | 2 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $468.73 | -33.86% | 2 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $265 → $320 | $555.92 | -42.44% | 3 | Dec 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $135 | $122.55 | +10.16% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $75 | $121.34 | -38.19% | 5 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $51.21 | - | 4 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $110 | $97.62 | +12.68% | 3 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $7.69 | - | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $91.51 | - | 4 | Apr 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $131.19 | - | 3 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $165 → $155 | $206.54 | -24.95% | 4 | Mar 27, 2020 |
Bio-Techne
Nov 20, 2025
Maintains: Buy
Price Target: $65 → $68
Current: $60.83
Upside: +11.79%
Thermo Fisher Scientific
Oct 29, 2025
Maintains: Buy
Price Target: $580 → $610
Current: $573.81
Upside: +6.31%
Hologic
Sep 19, 2025
Maintains: Buy
Price Target: $80 → $90
Current: $74.83
Upside: +20.27%
Medtronic
Aug 26, 2025
Maintains: Buy
Price Target: $105 → $115
Current: $100.77
Upside: +14.12%
Humana
Aug 14, 2025
Reiterates: Hold
Price Target: $282
Current: $256.66
Upside: +9.87%
Elevance Health
Jul 21, 2025
Downgrades: Hold
Price Target: n/a
Current: $341.04
Upside: -
GlobalFoundries
Jul 1, 2025
Initiates: Buy
Price Target: $52
Current: $40.42
Upside: +28.65%
UnitedHealth Group
Apr 21, 2025
Downgrades: Hold
Price Target: n/a
Current: $328.37
Upside: -
Integra LifeSciences Holdings
Mar 31, 2025
Upgrades: Buy
Price Target: n/a
Current: $13.66
Upside: -
AbbVie
Nov 4, 2024
Upgrades: Buy
Price Target: n/a
Current: $225.18
Upside: -
Sep 11, 2024
Maintains: Buy
Price Target: $115 → $125
Current: $198.21
Upside: -36.94%
Jun 28, 2024
Downgrades: Hold
Price Target: n/a
Current: $194.85
Upside: -
Jun 27, 2024
Maintains: Buy
Price Target: $300 → $340
Current: $315.38
Upside: +7.81%
Jun 24, 2024
Maintains: Buy
Price Target: $570 → $670
Current: $813.10
Upside: -17.60%
May 21, 2024
Upgrades: Buy
Price Target: $150
Current: $93.09
Upside: +61.13%
May 14, 2024
Maintains: Buy
Price Target: $770 → $840
Current: $993.64
Upside: -15.46%
Apr 1, 2024
Maintains: Buy
Price Target: $80 → $110
Current: $84.47
Upside: +30.22%
Mar 25, 2024
Upgrades: Buy
Price Target: n/a
Current: $261.99
Upside: -
Mar 22, 2024
Downgrades: Hold
Price Target: n/a
Current: $25.78
Upside: -
May 25, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $353.80
Upside: -12.38%
May 10, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $468.73
Upside: -33.86%
Dec 22, 2022
Maintains: Buy
Price Target: $265 → $320
Current: $555.92
Upside: -42.44%
Jul 28, 2022
Maintains: Buy
Price Target: $150 → $135
Current: $122.55
Upside: +10.16%
Jan 28, 2022
Upgrades: Buy
Price Target: $75
Current: $121.34
Upside: -38.19%
Nov 1, 2021
Downgrades: Hold
Price Target: n/a
Current: $51.21
Upside: -
Nov 1, 2021
Upgrades: Buy
Price Target: $110
Current: $97.62
Upside: +12.68%
Aug 2, 2021
Downgrades: Hold
Price Target: n/a
Current: $7.69
Upside: -
Apr 12, 2021
Downgrades: Hold
Price Target: n/a
Current: $91.51
Upside: -
Mar 10, 2021
Downgrades: Hold
Price Target: n/a
Current: $131.19
Upside: -
Mar 27, 2020
Reiterates: Buy
Price Target: $165 → $155
Current: $206.54
Upside: -24.95%